Skip to main content
Clinical Trials/NCT05402969
NCT05402969CompletedNot Applicable

Evaluation of Electrode-modiolus Distance and Cochlear Fibrosis Using Depth Sounding and Spectroscopy Tools: Comparison With Postoperative Cone Beam CT

University Hospital, Montpellier2 sites in 1 country180 target enrollmentStarted: January 6, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
180
Locations
2
Primary Endpoint
TIM profiles in patients with long-term implantation

Study Overview

Brief Summary

Cochlear fibrosis development can compromise the success and the outcomes of the cochlear implantation (CI) thus affecting the quality of life of the implanted patient. Correlating the results of the Transimpedance Matrix (TIM) measurements to the implant electrode location determined by the Cone Beam Computer Tomography (CBCT), this study aims to identify a range of TIM profiles within the implanted population, certain profiles suggesting the growth of the fibrosis tissue in cochlea

Detailed Description

Fibrosis tissue growth after the CI is an inflammatory reaction to a foreign body occurring around the electrode array. It is considered responsible for a larger current diffusion, less precise stimulation of auditory nerve fibres and elevated electrical impedances thus affecting the functioning and the battery life of an implant. Fibrosis has been also proposed as a factor reducing residual hearing. Hence, its early detection and prevention can significantly improve the outcomes of CI.

To date, no reliable technique to visualise cochlear fibrosis in vivo exists. However, the TIM measurement developed by Cochlear® including depth sounding and spectroscopy tools could possibly provide a better "view" of the fibrosis apparition after CI. This approach has been already successfully applied in the University Hospital of Montpellier, France, to the patients-users of the Advanced Bionics cochlear implants.

One of the factors provoking the fibrosis tissue development is an electrode positioning into the scala vestibule (SV) versus scala tympani (ST). CBCT will be used to visualise the electrode location as well as possible damages of the inner ear caused by CI. The imaging data will be then linked to the TIM measurements results.

Potential participants will be recruited from the French population of the Cochlear® implant users either coming for their regular checks-up at the ENT service of the University Hospital of Montpellier and implanted for more than 6 month (time necessary for the fibrosis tissue to develop) or recently implanted at the same hospital.

For the patients with long-term implantation (160 participants planned) the TIM measurements will be performed only once whereas the newly implanted group (20 participants planned) will require these measurements to be repeated several times: on the day of the surgery as well as 15 days, 1 month, 2 months, 3 months and 6 months after it. For the first group the post operational CBCT imaging file will be extracted from the patient medical record; for the second group CBCT will be performed during the surgery.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to 120 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Group with long-term implantation:
  • Age18 years or older
  • Affiliation to the French social security
  • Signed and dated informed consent form
  • Users of uni or bilateral cochlear implants for more than 6 months (CI24CA, CI422, CI512, CI522, CI532, CI612; CI622; CI632), in primo-implantation or reimplantation, with more than 18 electrodes active
  • Postoperation CBCT imaging results available
  • Recently-implanted group:
  • Age18 years or older
  • Affiliation to the French social security
  • Signed and dated informed consent form
  • Indication for CI622 or CI632 cochlear implants
  • Postoperation CBCT imaging results available

Exclusion Criteria

  • Vulnerable individuals (minors, adults protected in accordance to the French Public Health code, patients deprived of liberty by court decision)
  • Daily usage of the cochlear implant for less than 4 hours or weekly usage for less than 5 days
  • Failure or disfunction of the cochlear implant

Outcomes

Primary Outcomes

TIM profiles in patients with long-term implantation

Time Frame: Visit 1 (0 to 90 days after inclusion)

Comparison of TIM profiles of patients with ST electrode position versus patients with SV electrode dislocateon in the long-term implantation group

TIM profiles time dynamics in the recently implanted patients

Time Frame: Visit 1 - surgery (0 to 90 days after inclusion), visit 3, 4, 5, 6 (1, 2, 3 and 6 months after surgery)

Assessment of the TIM profile changes with time and depending on electrode scala position in newly-implanted patients

Secondary Outcomes

  • Spectroscopy of the specific electrode insertion zones(Visit 1 (0 to 90 days after inclusion))
  • TIM profiles depending on electrode array and inner ear access(Visit 1 (0 to 90 days after inclusion))
  • Depth sounding versus the distance electrode - spiral ganglion(Visit 1 (0 to 90 days after inclusion))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials